Pricing Log in Create free account

Revelation Biosciences, Inc. (REVB) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

Revelation Biosciences, Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. Revelation Biosciences, Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($3.2M and $3.0M). Revelation Biosciences, Inc. has the higher net margin (0.00% vs −650.3%) and the higher return on invested capital (0.00% vs −348.6%). Across the 12 metrics below, Revelation Biosciences, Inc. leads on 6 and 60 Degrees Pharmaceuticals Inc. on 6.

Valuation

Metric REVB SXTP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.88 9.71
P/B 0.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.86 n/m 0.64
EV/Sales n/m 2.04 9.21
Earnings yield (2,564.58%) (252.37%) (33.15%)
Free cash flow yield (513.59%) (397.08%) (25.50%)

Profitability

Metric REVB SXTP Biotechnology median
Gross margin 0.00% 43.42% 65.16%
Operating margin 0.00% (691.33%) 0.00%
Net margin 0.00% (650.34%) 0.00%
Free cash flow margin 0.00% (745.93%) 0.00%
Return on equity (276.43%) 110.82% (56.36%)
Return on assets (214.63%) (186.70%) (48.04%)
Return on invested capital 0.00% (348.64%) 0.00%

Growth

Metric REVB SXTP Biotechnology median
Revenue growth (TTM) — 23.41% 6.02%
EPS growth (last fiscal year) 97.72% 84.19% 30.26%
Revenue growth, 5-year CAGR — (11.18%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric REVB SXTP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.21 2.32 4.72
Net debt to EBITDA 1.18 0.37 0.96

Dividend

Metric REVB SXTP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric REVB SXTP Biotechnology median
Market cap 3.04m 3.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack